| scholarly article | Q13442814 |
| P50 | author | Henrik Zetterberg | Q6252048 |
| Kaj Blennow | Q28321550 | ||
| Per Johansson | Q52148201 | ||
| Ulf Andreasson | Q97016159 | ||
| P2093 | author name string | Johan Svensson | |
| Anders Wallin | |||
| Annika Öhrfelt | |||
| P2860 | cites work | DJ-1 has a role in antioxidative stress to prevent cell death | Q24306633 |
| Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism | Q24321359 | ||
| Recognition of the polyubiquitin proteolytic signal | Q24530006 | ||
| “Mini-mental state” | Q25938989 | ||
| Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease | Q27860795 | ||
| Ubiquitin carboxy-terminal hydrolase L1 binds to and stabilizes monoubiquitin in neuron | Q28589324 | ||
| The neuron-specific protein PGP 9.5 is a ubiquitin carboxyl-terminal hydrolase | Q28941761 | ||
| The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease | Q29547554 | ||
| Alzheimer's disease | Q29616743 | ||
| Mild cognitive impairment as a diagnostic entity | Q29619568 | ||
| Multiple monoubiquitination of RTKs is sufficient for their endocytosis and degradation | Q29622825 | ||
| Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria | Q30458193 | ||
| DJ-1 and alpha-synuclein in human cerebrospinal fluid as biomarkers of Parkinson's disease | Q30493811 | ||
| Ubiquitin carboxy-terminal hydrolase L1 (UCHL1) S18Y polymorphism in Alzheimer's disease | Q33764254 | ||
| Research criteria for subcortical vascular dementia in clinical trials | Q34015506 | ||
| Identification and preliminary characterization of ubiquitin C terminal hydrolase 1 (UCHL1) as a biomarker of neuronal loss in aneurysmal subarachnoid hemorrhage | Q34093020 | ||
| Cerebrospinal fluid and plasma biomarkers in Alzheimer disease | Q34098866 | ||
| The UCH-L1 gene encodes two opposing enzymatic activities that affect alpha-synuclein degradation and Parkinson's disease susceptibility | Q34157005 | ||
| Isolation of PGP 9.5, a new human neurone-specific protein detected by high-resolution two-dimensional electrophoresis | Q34256444 | ||
| Measurement of phosphorylated tau epitopes in the differential diagnosis of Alzheimer disease: a comparative cerebrospinal fluid study | Q34287865 | ||
| Ubiquitin is detected in neurofibrillary tangles and senile plaque neurites of Alzheimer disease brains | Q34620363 | ||
| Cerebrospinal fluid (CSF) 25-hydroxyvitamin D concentration and CSF acetylcholinesterase activity are reduced in patients with Alzheimer's disease | Q35060833 | ||
| Alzheimer's disease meets the ubiquitin-proteasome system | Q35935356 | ||
| The immunolocalization of protein gene product 9.5 using rabbit polyclonal and mouse monoclonal antibodies. | Q36051175 | ||
| Greater specificity for cerebrospinal fluid P-tau231 over P-tau181 in the differentiation of healthy controls from Alzheimer's disease | Q36412536 | ||
| Altered microRNA profiles in cerebrospinal fluid exosome in Parkinson disease and Alzheimer disease | Q36545671 | ||
| Ultrastructural localization of beta-amyloid, tau, and ubiquitin epitopes in extracellular neurofibrillary tangles | Q37426445 | ||
| Acute biomarkers of traumatic brain injury: relationship between plasma levels of ubiquitin C-terminal hydrolase-L1 and glial fibrillary acidic protein | Q37430560 | ||
| UCH-L1 Inhibition Decreases the Microtubule-Binding Function of Tau Protein | Q38829786 | ||
| Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study | Q40349700 | ||
| Differential diagnosis of Alzheimer disease with cerebrospinal fluid levels of tau protein phosphorylated at threonine 231. | Q44091581 | ||
| Oxidative modifications and down-regulation of ubiquitin carboxyl-terminal hydrolase L1 associated with idiopathic Parkinson's and Alzheimer's diseases | Q44727052 | ||
| UCHL1 is a Parkinson's disease susceptibility gene | Q47866612 | ||
| The ubiquitin pathway in Parkinson's disease | Q48015939 | ||
| Cerebrospinal fluid profile of amyloid β42 (Aβ42), hTau and ubiquitin in North Indian Alzheimer's disease patients. | Q48143268 | ||
| Proteomics analysis of the Alzheimer's disease hippocampal proteome | Q48157842 | ||
| Ubiquitin in cerebrospinal fluid in Alzheimer's disease and vascular dementia. | Q48213108 | ||
| Reduced cerebrospinal fluid level of thyroxine in patients with Alzheimer's disease | Q48292097 | ||
| Elevated levels of cerebrospinal fluid neuron-specific enolase (NSE) in Alzheimer's disease | Q48310556 | ||
| Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop | Q48342894 | ||
| Cerebrospinal fluid neuron-specific enolase is reduced in Alzheimer's disease | Q48379690 | ||
| CSF phosphorylated tau protein correlates with neocortical neurofibrillary pathology in Alzheimer's disease | Q48408159 | ||
| Analysis of functional polymorphisms in three synaptic plasticity-related genes (BDNF, COMT AND UCHL1) in Alzheimer's disease in Colombia | Q48541163 | ||
| Genetic association between Ubiquitin Carboxy-terminal Hydrolase-L1 gene S18Y polymorphism and sporadic Alzheimer's disease in a Chinese Han population | Q48576454 | ||
| Cerebrospinal fluid {beta}-amyloid 42 and tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain | Q48710955 | ||
| Neuron-specific enolase, S-100 protein, myelin basic protein and lactate in CSF in dementia | Q48721686 | ||
| Ubiquitin carboxyl-terminal hydrolase (PGP 9.5) is selectively present in ubiquitinated inclusion bodies characteristic of human neurodegenerative diseases | Q48960752 | ||
| Cerebrospinal fluid neuron-specific enolase: a further marker of Alzheimer's disease? | Q49020317 | ||
| CSF ubiquitin as a specific biomarker in Alzheimer's disease. | Q50649289 | ||
| Accuracy of a panel of 5 cerebrospinal fluid biomarkers in the differential diagnosis of patients with dementia and/or parkinsonian disorders. | Q50940972 | ||
| Cerebrospinal fluid biomarkers for Alzheimer’s disease: diagnostic performance in a homogeneous mono-center population. | Q51020848 | ||
| Increased Cerebrospinal Fluid Level of Insulin-like Growth Factor-II in Male Patients with Alzheimer's Disease. | Q52148895 | ||
| Cerebrospinal fluid neuron-specific enolase in Alzheimer's disease and vascular dementia. | Q53202334 | ||
| Detection of tau phosphorylated at threonine 231 in cerebrospinal fluid of Alzheimer's disease patients. | Q53235955 | ||
| Ubiquitin is a component of paired helical filaments in Alzheimer's disease. | Q53303482 | ||
| Intact protein analysis of ubiquitin in cerebrospinal fluid by multiple reaction monitoring reveals differences in Alzheimer's disease and frontotemporal lobar degeneration. | Q53355443 | ||
| S18Y in ubiquitin carboxy-terminal hydrolase L1 (UCH-L1) associated with decreased risk of Parkinson's disease in Sweden | Q57248429 | ||
| Serum but not cerebrospinal fluid levels of insulin-like growth factor-I (IGF-I) and IGF-binding protein-3 (IGFBP-3) are increased in Alzheimer's disease | Q57675752 | ||
| Ubiquitin is conjugated with amino-terminally processed tau in paired helical filaments | Q70462570 | ||
| Neuron specific enolase in cerebrospinal fluid: a biochemical marker for neuronal degeneration in dementia disorders? | Q72232429 | ||
| Effects of hemolysis and storage condition on neuron-specific enolase (NSE) in cerebrospinal fluid and serum: implications in clinical practice | Q81366189 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cerebrospinal fluid | Q54196 |
| Alzheimer's disease | Q11081 | ||
| P304 | page(s) | 283-294 | |
| P577 | publication date | 2016-05-01 | |
| P1433 | published in | Dementia and geriatric cognitive disorders extra | Q27723818 |
| P1476 | title | Increased Cerebrospinal Fluid Levels of Ubiquitin Carboxyl-Terminal Hydrolase L1 in Patients with Alzheimer's Disease | |
| P478 | volume | 6 |
| Q55437118 | A proteomic approach reveals the differential protein expression in Drosophila melanogaster treated with red ginseng extract (Panax ginseng). |
| Q37699616 | Impaired NGF/TrkA Signaling Causes Early AD-Linked Presynaptic Dysfunction in Cholinergic Primary Neurons |
| Q47708649 | Mass Spectrometric Analysis of Cerebrospinal Fluid Ubiquitin in Alzheimer's Disease and Parkinsonian Disorders |
| Q58697859 | Plasma Markers of Neurodegeneration Are Raised in Friedreich’s Ataxia |
| Q42369990 | The Decrease of Uch-L1 Activity Is a Common Mechanism Responsible for Aβ 42 Accumulation in Alzheimer's and Vascular Disease |
Search more.